| Symbol | MGRX |
|---|---|
| Name | MANGOCEUTICALS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Misc Health and Biotechnology Services |
| Address | Texas, 75248, United States |
| Telephone | (833) 626-4679 |
| Fax | — |
| — | |
| Website | https://www.mangoceuticals.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001938046 |
| Description | Mangoceuticals, Inc. focuses on develops, markets, and sells various mens wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc. Additional info from NASDAQ: |
MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders
Read moreMangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination
Read moreNew Form 425 - MANGOCEUTICALS, INC. <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 0001493152-26-035498 <b>Size:</b> 45 KB
Read more(75% Positive) MANGOCEUTICALS, INC. (MGRX) Announces Business Combination
Read moreMangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology
Read moreNew Form 425 - MANGOCEUTICALS, INC. <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 0001493152-26-035324 <b>Size:</b> 1 MB
Read moreNew Form 10-K - MANGOCEUTICALS, INC. <b>Filed:</b> 2026-04-01 <b>AccNo:</b> 0001493152-26-014478 <b>Size:</b> 16 MB
Read moreMangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
Read more